Short answer · Medically reviewed summary · Last updated: 2026-04-07
Ledderhose disease, also medically referred to as plantar fibromatosis, is a rare, benign proliferative disorder characterized by the development of nodules on the sole of the foot. The condition is frequently known by several synonyms, including Morbus Ledderhose, plantar fibroma, or simply plantar fibromatosis, all of which describe the same underlying condition of fibrous tissue thickening in the plantar fascia. What are the common synonyms and clinical names for Ledderhose disease? In medical literature and clinical records, Ledderhose disease is most commonly documented as plantar fibromatosis.
Ledderhose disease, also medically referred to as plantar fibromatosis, is a rare, benign proliferative disorder characterized by the development of nodules on the sole of the foot. The condition is frequently known by several synonyms, including Morbus Ledderhose, plantar fibroma, or simply plantar fibromatosis, all of which describe the same underlying condition of fibrous tissue thickening in the plantar fascia.
In medical literature and clinical records, Ledderhose disease is most commonly documented as plantar fibromatosis. Because it was first described by the German surgeon Georg Ledderhose in 1894, it is frequently referred to as Morbus Ledderhose, particularly in European medical traditions. While these terms are used interchangeably, patients may also encounter the condition labeled as "plantar fibroma" when referring to the specific nodules themselves, or "plantar fascia fibromatosis" when describing the involvement of the connective tissue. Understanding these names is essential for patients navigating medical databases, as different healthcare systems may prioritize the descriptive term over the eponymous one.
The variety of names for Ledderhose disease stems from the historical practice of naming medical conditions after the physicians who first characterized them, combined with the later shift toward descriptive, pathology-based terminology. In the late 19th century, identifying a condition by the discoverer's name (eponym) was standard. However, as medical classification systems evolved to prioritize clarity and biological accuracy, "plantar fibromatosis" became the preferred clinical term. This dual-naming convention often leads to confusion in medical records, but both terms point to the same pathology: the non-malignant thickening of the plantar fascia.
Major medical classification systems use specific codes to categorize Ledderhose disease, ensuring consistency for researchers and clinicians. These official classifications are crucial for health insurance coding and clinical research:
While "plantar fibromatosis" is the most precise descriptive term currently used in clinical practice, many podiatrists and orthopedic surgeons still recognize "Ledderhose disease" immediately due to its historical significance. If you are preparing for a consultation, using the term "plantar fibromatosis" is generally the most effective way to ensure clear communication with modern clinical teams. Currently, 95 people with Ledderhose disease have joined the DiseaseMaps community, sharing their experiences with these various labels and helping others navigate the diagnostic journey more effectively.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the guidance of your physician or other qualified health provider with any questions regarding a medical condition.